Highbridge Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-26,779
Closed -$2.87M 442
2018
Q3
$2.87M Buy
+26,779
New +$2.68M 0.07% 284
2017
Q2
Sell
-100,000
Closed -$8.16M 1434
2017
Q1
$8.41M Buy
100,000
+22,999
+30% +$1.84M 0.12% 216
2016
Q4
$5.66M Buy
77,001
+71,361
+1,265% +$5.31M 0.1% 230
2016
Q3
$452K Buy
+5,640
New +$451K 0.01% 830
2016
Q1
Sell
-9,325
Closed -$785K 1668
2015
Q4
$785K Sell
9,325
-1,312
-12% -$109K 0.01% 840
2015
Q3
$890K Buy
+10,637
New +$898K 0.01% 817
2015
Q1
Sell
-5,319
Closed -$367K 1498
2014
Q4
$367K Buy
+5,319
New +$359K ﹤0.01% 905
2014
Q2
Sell
-594,250
Closed -$35.5M 1192
2014
Q1
$35M Sell
594,250
-315,743
-35% -$17.6M 0.44% 71
2013
Q4
$46.4M Sell
909,993
-6,958
-0.8% -$348K 0.56% 54
2013
Q3
$46.1M Buy
916,951
+132,605
+17% +$6.94M 0.49% 39
2013
Q2
$38.5M Buy
+784,346
New +$42.7M 0.38% 49

Other funds holding LLY

Highbridge Capital Management's LLY Position: Q4 2018 in Review

Highbridge Capital Management sold out of Eli Lilly (LLY) in Q4 2018, closing a stake of 26,779 shares — an estimated $2.87M sold.

Highbridge Capital Management first reported a position in LLY in Q2 2013 and held it in 11 quarters. The position peaked at $46.4M in Q4 2013. 1,560 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

  • Highbridge Capital Management reported no remaining Eli Lilly position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 26,779 Eli Lilly shares in Q4 2018, an estimated $2.87M.
  • Highbridge Capital Management first reported a position in Eli Lilly in Q2 2013 and held it in 11 quarters.
  • Highbridge Capital Management's Eli Lilly position peaked at $46.4M in Q4 2013.
  • 1,560 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.